On Monday, Borregaard ASA (BRG:NO) (OTC: BRRDF), a Norwegian biochemical firm, obtained an improve in its inventory score from Maintain to Purchase by Berenberg.
The agency additionally elevated the value goal for Borregaard’s shares from NOK175.00 to NOK225.00. This adjustment displays a constructive outlook on the corporate’s evolving enterprise technique and its capability to adapt in a difficult financial surroundings.
The improve comes after Borregaard’s investor day, which passed off on September 18, the place the corporate described itself as being at “the dawn” of its specialization journey. Berenberg’s evaluation means that Borregaard has already made important strides past this early section.
The agency acknowledges Borregaard as a extremely differentiated entity inside the chemical sector, with a robust observe report of adjusting its product combine to navigate adversarial macroeconomic circumstances.
Borregaard’s monetary efficiency is highlighted as proof of its resilience and flexibility, particularly over the previous two troublesome years for the chemical trade. Regardless of these challenges, Borregaard has demonstrated its functionality to keep up and even develop its monetary standing.
The journey in direction of specialization has been useful for Borregaard, with its EBITDA growing considerably over the previous years. From an EBITDA of EUR64 million in 2010, Berenberg estimates that it’s going to attain EUR160 million in 2024. This progress trajectory is seen as a testomony to the corporate’s profitable technique and execution.
Along with commenting on the corporate’s monetary journey, Berenberg shared insights from a latest go to to Borregaard’s Sarpsborg mill and ideas on the upcoming CEO succession. The agency’s revised funding case for Borregaard displays a complete overview of those parts, underpinning the choice to improve the inventory score and lift the value goal.
This text was generated with the help of AI and reviewed by an editor. For extra data see our T&C.
